CIVITAS THERAPEUTICS, INC.
Profile
Company Names
CIVITAS THERAPEUTICS, INC.
Addresses
190 EVERETT AVENUE, CHELSEA, MA 02150
Phone Numbers
617-968-3004
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2009
State Incorporated:
DELAWARE
Total Amount Raised:
$107,814,705.00
Number of Funding Rounds:
3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2014-08-22
$55,250,000.00
$55,250,000.00
$0.00
Equity
2
2013-09-03
$38,299,999.00
$38,299,999.00
$0.00
Equity
1
2010-12-27
$14,264,706.00
$28,600,000.00
$14,335,294.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
GLENN
BATCHELDER
EXECUTIVE OFFICER, DIRECTOR
RICHARD
BATYCKY
EXECUTIVE OFFICER
ANDREA
FRANZ
EXECUTIVE OFFICER
MARTIN
FREED
EXECUTIVE OFFICER
DAVID
HIRSCH
DIRECTOR
NCRX OPTICAL SOLUTIONS INC
| PRECISION THERAPEUTICS INC
| TURIYA MEDIA, INC.
| CIVITAS THERAPEUTICS, INC.
| COLLEGIUM PHARMACEUTICAL INC
| SONGZA, INC.
| RAPID MICRO BIOSYSTEMS, INC.
| METAMORPHIC VENTURES II, L.P.
| METAMORPHIC VENTURES II-A, L.P.
| VOYAT INC.
| LAUNCHKEY, INC.
| ONEX YORK CO-INVEST LP
| COLLEGIUM PHARMACEUTICAL, INC
| MOVE LOOT, INC.
| METAMORPHIC VENTURES FD, LLC
| VELICEPT THERAPEUTICS, INC.
| GROOP INTERNET PLATFORM INC.
| ZAVANTE THERAPEUTICS, INC.
| TRICIDA, INC.
| MOLECULAR TEMPLATES, INC.
| POSEIDA THERAPEUTICS, INC.
| AMUNIX PHARMACEUTICALS, INC.
| SWIFT HOLDCO LTD
| WKCGRG HOLDINGS, INC.
ROB
HOPFNER
DIRECTOR
ROBERT
HOPFNER
DIRECTOR
MARK
IWICKI
EXECUTIVE OFFICER, DIRECTOR
BLAIR
JACKSON
DIRECTOR
AIDAN
KING
DIRECTOR
ROBERT
ROCHE
DIRECTOR
RAJEEV
SHAH
DIRECTOR
CIVITAS THERAPEUTICS, INC.
| KALA PHARMACEUTICALS, INC.
| RA PHARMACEUTICALS, INC.
| SATSUMA PHARMACEUTICALS, INC.
| EIDOS THERAPEUTICS, INC.
| BLACK DIAMOND THERAPEUTICS, INC.
| RA CAPITAL HEALTHCARE FUND LP
| RA CAPITAL HEALTHCARE INTERNATIONAL FUND LTD
| SOLID BIOSCIENCES INC.
| RA CAPITAL NEXUS INTERNATIONAL FUND, L.P.
| RA CAPITAL NEXUS FUND, L.P.
| CELONA, INC.
| RA CAPITAL NEXUS INTERNATIONAL FUND III, L.P.
| RA CAPITAL NEXUS FUND III, L.P.
| ABCURO, INC.
| RA CAPITAL PLANETARY HEALTH FUND, L.P.
| RA CAPITAL PLANETARY HEALTH INTERNATIONAL FUND, L.P.
TIM
SHANNON
DIRECTOR
NOVIRA THERAPEUTICS, INC.
| ARVINAS, INC.
| CIVITAS THERAPEUTICS, INC.
| CYTOMX THERAPEUTICS, INC.
| VIVACE THERAPEUTICS, INC.
| SPYRYX BIOSCIENCES, INC.
| ARVINAS HOLDING COMPANY, LLC
| NEXTCURE, INC.
| HALDA THERAPEUTICS, LLC
| RALLYBIO HOLDINGS, LLC
| CAPITAL INTEGRATION SYSTEMS LLC
| AER THERAPEUTICS, INC.
TIMOTHY
SHANNON
DIRECTOR
TRAXIS EMERGING MARKETS EQUITY OFFSHORE FUND LTD.
| TRAXIS EMERGING MARKETS OPPORTUNITIES OFFSHORE FUND LTD.
| HELIX THERAPEUTICS, INC.
| CIVITAS THERAPEUTICS, INC.
| ALDEA PHARMACEUTICALS, INC.
| VAXINNATE CORP
| CORNOVUS PHARMACEUTICALS INC.
| IDEAYA BIOSCIENCES, INC.
| ARVINAS, INC.
| INIVATA LTD
| SIDUMA THERAPEUTICS, INC.
| NORMUNITY HOLDING COMPANY, LLC
| LAND MEDICINE INC.
| TRITON THERAPEUTICS, INC.
| QUARRY GLUE HOLDING CO LLC
MARY
TAYLOR
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2014-08-22
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

